The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Health Care Reform

Biotech Trends Update — Biosimilars: FDA Meeting in November to Discuss BCPI Act Implementation

Adam Feuerstein at TheStreet.com reported this morning on a draft FDA notice for a planned November meeting on implementation of the Biologics Price Competition and Innovation Act, which was passed as part of the healthcare reform legislation. The BPCI Act (42 U.S.C. 262(k)(8)) provides for the FDA to author guidance “with respect to the licensure [...]

Biotech Trends Update — Personalized Medicine: The Case for Diagnostics Focuses on Cost and Effectiveness

A report in FierceBiotech today distilled the views of three life science VCs on trends to watch in 2010.  Along with other worthwhile observations (and I’d encourage you to read the whole thing) was this bullet pointing out the value of personalized medicine in addressing comparative effectiveness concerns: “Interest in molecular diagnostics is heating up. It’s [...]

In Praise of Universal Coverage From a Genomics Perspective

This could be the last chance in the U.S. to make good decisions about health care.  Why? Because now, before genome sequencing is fast and cheap and universal, we are in a political position rarely experienced outside philosophy books: we are still in the “original position,” behind the “veil of ignorance.”  I’ll try to make this [...]

White House Weekly Address: The Pitch for Health Reform

With the critical Senate Finance bill still pending, here’s the pitch from the White House: The only two things I heard Obama describe as requirements for a bill he would sign: No addition to the deficit over 10 years; and Insurance exchange: one-stop shop to compare prices, coverage and, interestingly, track record. He definitely advocated [...]

BIO 2009: Wednesday Keynote Lunch Panel on Health Reform Live-ish Blog Part 2

More from panelists Tom Daschle, Bill Frist, Karl Rove and Howard Dean, and moderator health journalist Susan Dentzer (Editor-in-Chief, Health Affairs). Click here for part 1. Next topic: process. Regular legislative process or reconciliation? TD – No reconciliation needed as long as current process (esp. Senate Finance Committee) continues to work well in a bipartisan [...]

BIO 2009: Wednesday Keynote Lunch Panel on Health Reform Live-ish Blog

The panelists today are Tom Daschle, Bill Frist, Karl Rove and Howard Dean, and the moderator is health journalist Susan Dentzer (Editor-in-Chief, Health Affairs). First topic: Harry and Louise (Susan calls them The Two Horsepeople of the Healthcare Apocalypse). Where are they today? TD – Want to get something done, concerned about costs of healthcare. [...]

What You Missed While You Were at BioFinance

A lot to catch up on over the last few days… A professor in Hong Kong says don’t relax just because flu cases outside of Mexico have been mild — more spread equals more chances for further mutation. You think Biden had a bad public speaking week?  Check this one out from the Environment Minister [...]

Health Care Reform: Party’s Over for Medical Imaging

Well…it could be worse, but one could argue it’s the beginning of a slow decline for the medical imaging market in the U.S.  On Tuesday, Senator Baucus (D-Montana) and Senator Grassley (R-Iowa), Chairman and Ranking Member of the Senate Finance Committee, released a description of policy options for healthcare reform.  The options included “Transparency and Evidence-Based Decision-Making for Imaging Services,” proposing a [...]

BioFinance Lunch Keynote: U.S. Health Reform

Just finished listening to Scott Gottlieb at the BioFinance lunch keynote. Scott was Deputy Commissioner at the FDA in the Bush administration, and is now a Fellow at the American Enterpirse Institute. Here’s what he had to say. Stay tuned for questions from the audience, including Dani and I, at the end… Healthcare in the [...]

Follow

Get every new post delivered to your Inbox.

Join 84 other followers